- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological treatment options for mast cell activation disease
Authors
Keywords
Mast cell, Mast cell activation disease, Systemic mastocytosis, Systemic mast cell activation syndrome, Therapy
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 389, Issue 7, Pages 671-694
Publisher
Springer Nature
Online
2016-04-30
DOI
10.1007/s00210-016-1247-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties
- (2016) Asuka Baba et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Mast cell stabilisers
- (2016) Tao Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mast cell proteases as pharmacological targets
- (2016) George H. Caughey EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of ONO-4053 on Fc Epsilon RI Stimulated-Mast Cell Activation
- (2016) Shinsuke Yamaguchi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Response of patients with indolent systemic mastocytosis to tamoxifen citrate
- (2016) Joseph H. Butterfield et al. LEUKEMIA RESEARCH
- Transgenerational transmission of systemic mast cell activation disease—genetic and epigenetic features
- (2016) Gerhard J. Molderings Translational Research
- Regulation of human skin mast cell histamine release by PDE inhibitors
- (2015) N. Eskandari et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- H1-antihistamines for primary mast cell activation syndromes: a systematic review
- (2015) U. B. Nurmatov et al. ALLERGY
- Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis
- (2015) Nicole Randall et al. AMERICAN JOURNAL OF HEMATOLOGY
- Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
- (2015) Paolo Strati et al. AMERICAN JOURNAL OF HEMATOLOGY
- Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis
- (2015) S. Barete et al. BLOOD
- Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases
- (2015) Lawrence B. Afrin et al. BRAIN BEHAVIOR AND IMMUNITY
- Concurrent activatingKITmutations in systemic mastocytosis
- (2015) Terra Lasho et al. BRITISH JOURNAL OF HAEMATOLOGY
- The genetic basis of mast cell activation disease - looking through a glass darkly
- (2015) Gerhard J. Molderings CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Successful treatment of mast cell activation syndrome with sunitinib
- (2015) Lawrence B. Afrin et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
- (2015) Zuyi Weng et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
- (2015) Andreas Hochhaus et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- How do basic secretagogues activate mast cells?
- (2015) Roland Seifert NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Luteolin 8-C-β-fucopyranoside downregulates IL-6 expression by inhibiting MAPKs and the NF-κB signaling pathway in human monocytic cells
- (2015) Young Seoung Lee et al. Pharmacological Reports
- Abstract 746: PKC412 (Midostaurin) is safe and highly effective in systemic mastocytosis patients: Follow up of a single-center Italian compassionate use
- (2015) Cristina Papayannidis et al. CANCER RESEARCH
- Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy
- (2015) Shannon R. M. Kinney et al. PLoS One
- Epidemiology of systemic mastocytosis in Denmark
- (2014) Sarah S. Cohen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sustained improvement in urticaria pigmentosa and pruritus in a case of indolent systemic mastocytosis treated with cladribine
- (2014) A. D. Lock et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Systemische Mastzellaktivierungserkrankung: Ein praxisorientierter Leitfaden zu Diagnostik und Therapie
- (2014) G. Molderings et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Cinnamaldehyde is the main mediator of cinnamon extract in mast cell inhibition
- (2014) Yvonne Hagenlocher et al. EUROPEAN JOURNAL OF NUTRITION
- Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy
- (2014) S. Bibi et al. HAEMATOLOGICA
- Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease
- (2014) Britta Haenisch et al. IMMUNOGENETICS
- Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo
- (2014) Atsuo Tanimoto et al. INFLAMMATION RESEARCH
- Molecular targets on mast cells and basophils for novel therapies
- (2014) Ilkka T. Harvima et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Induction Of Remission Of Frequent Idiopathic Anaphylaxis With Rituximab
- (2014) Arturo Borzutzky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
- (2014) Celalettin Ustun et al. JOURNAL OF CLINICAL ONCOLOGY
- Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing -Catenin Signaling
- (2014) B. Jin et al. MOLECULAR CANCER THERAPEUTICS
- Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions
- (2014) Benjamin D. McNeil et al. NATURE
- Palmitoylethanolamide in CNS health and disease
- (2014) Giuseppina Mattace Raso et al. PHARMACOLOGICAL RESEARCH
- Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation
- (2014) José Alves Gurgel et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial
- (2013) F. Siebenhaar et al. ALLERGY
- Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management
- (2013) Animesh Pardanani AMERICAN JOURNAL OF HEMATOLOGY
- The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis
- (2013) Philipp Erben et al. ANNALS OF HEMATOLOGY
- Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study
- (2013) Bérengère Gruson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Twenty-first century mast cell stabilizers
- (2013) D F Finn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chirurgische Eingriffe an Patienten mit Mastzellüberaktivitätserkrankung
- (2013) B. Sido et al. CHIRURG
- Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis
- (2013) I. J. Chan et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Expanding Spectrum of Mast Cell Activation Disorders: Monoclonal and Idiopathic Mast Cell Activation Syndromes
- (2013) Matthieu Picard et al. CLINICAL THERAPEUTICS
- Masitinib (AB1010), from canine tumor model to human clinical development: Where we are?
- (2013) Ilaria Marech et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Mastocytosis: update on pharmacotherapy and future directions
- (2013) Juan Carlos Cardet et al. EXPERT OPINION ON PHARMACOTHERAPY
- Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V
- (2013) K. V. Gleixner et al. HAEMATOLOGICA
- KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis
- (2013) Sigurd Broesby-Olsen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis
- (2013) Alfonso Quintás-Cardama et al. LEUKEMIA & LYMPHOMA
- Mast Cell Activation Syndrome Masquerading as Agranulocytosis
- (2013) Lawrence B. Afrin MILITARY MEDICINE
- Molecular mechanisms of glucocorticoid action in mast cells
- (2013) Emmanuel Oppong et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases
- (2013) Alexander F. Hagel et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Familial Occurrence of Systemic Mast Cell Activation Disease
- (2013) Gerhard J. Molderings et al. PLoS One
- A Case of Systemic Mastocytosis Associated with Acute Myeloid Leukemia Terminating as Aleukemic Mast Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
- (2013) Mi Hyun Bae et al. Annals of Laboratory Medicine
- Urticaria pigmentosa in a female patient with celiac disease: Response to a gluten-free diet
- (2012) L. Rodrigo et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab
- (2012) Matthew C. Bell et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Mast cell apoptosis induced by siramesine, a sigma-2 receptor agonist
- (2012) Jane Spirkoski et al. BIOCHEMICAL PHARMACOLOGY
- Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells
- (2012) V. R. Simhadri et al. BLOOD
- Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation
- (2012) T Gromke et al. BONE MARROW TRANSPLANTATION
- The effects of botulinum toxin A on mast cell activity: Preliminary results
- (2012) Tae Hwan Park BURNS
- Effective Treatment of Edema and Endothelial Barrier Dysfunction With Imatinib
- (2012) Jurjan Aman et al. CIRCULATION
- Calcineurin inhibitors in chronic urticaria
- (2012) Timothy D. Trojan et al. Current Opinion in Allergy and Clinical Immunology
- Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells
- (2012) Sandra Lechowski et al. EUROPEAN JOURNAL OF NUTRITION
- Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions
- (2012) Dina S. El-Agamy EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibitory effects of benzodiazepines on the adenosine A2B receptor mediated secretion of interleukin-8 in human mast cells
- (2012) Kristina Hoffmann et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics
- (2012) Britta Haenisch et al. IMMUNOLOGY
- Serotonin and its 5-HT1 receptor in human mastocytosis
- (2012) Markus Ritter et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The Effect of Anti-IL-5 Therapy on Esophageal Mastocytosis in Pediatric Eosinophilic Esophagitis
- (2012) I.M. Otani et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Prevalence of indolent systemic mastocytosis in a Dutch region
- (2012) Jasper J. van Doormaal et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Miltefosine: a novel treatment option for mast cell-mediated diseases
- (2012) Marcus Maurer et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Mast cells: an expanding pathophysiological role from allergy to other disorders
- (2012) Preet Anand et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Imatinib mesylate alleviates diarrhea in a mouse model of intestinal allergy
- (2012) K. Vaali et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans
- (2012) Zuyi Weng et al. PLoS One
- Allergic Mastocytic Gastroenteritis and Colitis: An Unexplained Etiology in Chronic Abdominal Pain and Gastrointestinal Dysmotility
- (2012) A. Akhavein M et al. Gastroenterology Research and Practice
- Evidence for Methotrexate as a Useful Treatment for Steroid-dependent Chronic Urticaria
- (2011) L Sagi et al. ACTA DERMATO-VENEREOLOGICA
- Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice
- (2011) K. Yamaki et al. ALLERGY
- Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial
- (2011) Jessica R Biesiekierski et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Interferon Alpha and Pamidronate in Osteoporosis with Fracture Secondary to Mastocytosis
- (2011) Michel Laroche et al. AMERICAN JOURNAL OF MEDICINE
- Polycythemia From Mast Cell Activation Syndrome: Lessons Learned
- (2011) Lawrence B. Afrin et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- The kaleidoscope of glucorticoid effects on immune system
- (2011) Margherita Zen et al. AUTOIMMUNITY REVIEWS
- KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib
- (2011) K. V. Gleixner et al. BLOOD
- Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis
- (2011) Alfonso Quintás-Cardama et al. CANCER
- Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536
- (2011) B. Peter et al. HAEMATOLOGICA
- Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
- (2011) Gerhard J. Molderings et al. INTERNAL MEDICINE
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
- (2011) Peter Valent et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Inhibition of anaphylaxis like reaction and mast cell activation by Sitagliptin
- (2011) Manar A. Nader INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibitors of Dipeptidyl Peptidase I (DPPI) as Mast Cell Stabilising Agents: The Contribution of DPPI in Mast Cell Activation
- (2011) G. El-Feki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations
- (2011) Matthew J. Hamilton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Amitriptyline and Prochlorperazine Inhibit Proinflammatory Mediator Release From Human Mast Cells
- (2011) Anthony Clemons et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
- (2011) Gerhard J Molderings et al. Journal of Hematology & Oncology
- Refractory Symptoms Successfully Treated with Leukotriene Inhibition in a Child with Systemic Mastocytosis
- (2011) PAUL J. TURNER et al. PEDIATRIC DERMATOLOGY
- Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs
- (2011) Rauno Joks et al. PHARMACOLOGICAL RESEARCH
- Targeting chemokine receptors in chronic inflammatory diseases: An extensive review
- (2011) Pim J. Koelink et al. PHARMACOLOGY & THERAPEUTICS
- Response to cladribine in patient with systemic mastocytosis
- (2011) Milica Radojkovic et al. Vojnosanitetski Pregled
- Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study
- (2010) Carle Paul et al. AMERICAN JOURNAL OF HEMATOLOGY
- Acetylsalicylic acid and montelukast block mast cell mediator–related symptoms during rapid desensitization
- (2010) Rebecca G. Breslow et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Omalizumab monotherapy for bee sting and unprovoked “anaphylaxis” in a patient with systemic mastocytosis and undetectable specific IgE
- (2010) Kalliopi Kontou-Fili et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- How I treat patients with advanced systemic mastocytosis
- (2010) P. Valent et al. BLOOD
- AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit
- (2010) T.-Y. Lin et al. BLOOD
- Biological implications of preformed mast cell mediators
- (2010) Anders Lundequist et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Maintenance therapy in acute myeloid leukemia revisited: will new agents rekindle an old interest?
- (2010) Utz Krug et al. CURRENT OPINION IN HEMATOLOGY
- In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
- (2010) Alexandra Böhm et al. EXPERIMENTAL HEMATOLOGY
- KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406)
- (2010) Barbara Peter et al. EXPERIMENTAL HEMATOLOGY
- Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects
- (2010) Gerhard J. Molderings et al. IMMUNOGENETICS
- Pimecrolimus Induces Apoptosis of Mast Cells in a Murine Model of Cutaneous Mastocytosis
- (2010) Zhongcai Ma et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Mast cell activation disorder masquerading as pure red cell aplasia
- (2010) Lawrence B. Afrin INTERNATIONAL JOURNAL OF HEMATOLOGY
- Mast cell activation syndrome: Proposed diagnostic criteria
- (2010) Cem Akin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The BH3-Mimetic ABT-737 Induces Mast Cell Apoptosis In Vitro and In Vivo: Potential for Therapeutics
- (2010) M. Karlberg et al. JOURNAL OF IMMUNOLOGY
- Inhibition of JAK–STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells
- (2010) T Lasho et al. LEUKEMIA
- Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis
- (2010) Sameer A. Parikh et al. LEUKEMIA & LYMPHOMA
- G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil Sodium
- (2010) Yuhua Yang et al. PHARMACOLOGY
- Pro-apoptotic Bax is the major and Bak an auxiliary effector in cytokine deprivation-induced mast cell apoptosis
- (2010) M Karlberg et al. Cell Death & Disease
- Epigenetic targets of bioactive dietary components for cancer prevention and therapy
- (2010) Syed M. Meeran et al. Clinical Epigenetics
- Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
- (2009) Ken H. Lim et al. AMERICAN JOURNAL OF HEMATOLOGY
- Sunitinib
- (2009) Georgios S. Papaetis et al. BIODRUGS
- Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs
- (2009) K. J. Aichberger et al. BLOOD
- Combination of KIT gene silencing and tocopherol succinate may offer improved therapeutic approaches for human mastocytosis
- (2009) Irene Ruano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Inhibitors of Deacetylases Suppress Oncogenic KIT Signaling, Acetylate HSP90, and Induce Apoptosis in Gastrointestinal Stromal Tumors
- (2009) T. Muhlenberg et al. CANCER RESEARCH
- Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells
- (2009) T. Shimoda et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Successful Treatment of KIT D816V-positive, Imatinib-resistant Systemic Mastocytosis with Interferon-alpha
- (2009) Chikamasa Yoshida et al. INTERNAL MEDICINE
- Successful treatment of chronic drug-resistant urticaria with alprazolam
- (2009) Antonio Dueñas-Laita et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis
- (2009) Arturo Vega-Ruiz et al. LEUKEMIA RESEARCH
- Survey of aspirin administration in systemic mastocytosis
- (2009) Joseph H. Butterfield PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Cysteinyl Leukotrienes Enhance the Degranulation of Bone Marrow-Derived Mast Cells through the Autocrine Mechanism
- (2009) Izumi Kaneko et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress
- (2008) Esra Çikler et al. ACTA HISTOCHEMICA
- Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases
- (2008) M. Tachibana et al. ALLERGY
- Thalidomide in advanced mastocytosis
- (2008) Gandhi Damaj et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
- Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis
- (2008) S. Verstovsek et al. CLINICAL CANCER RESEARCH
- Dasatinib therapy for systemic mastocytosis: four cases
- (2008) Duncan Purtill et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors
- (2008) Tzu-Yin Lin et al. EXPERIMENTAL HEMATOLOGY
- Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production
- (2008) Joseph H. Butterfield et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Advanced mast cell disease: an Italian Hematological Multicenter experience
- (2008) Livio Pagano et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Miltefosine Inhibits Human Mast Cell Activation and Mediator Release Both In Vitro and In Vivo
- (2008) Karsten Weller et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation
- (2008) D. De Filippis et al. JOURNAL OF NEUROENDOCRINOLOGY
- Lenalidomide therapy in systemic mastocytosis
- (2008) Hanneke C. Kluin-Nelemans et al. LEUKEMIA RESEARCH
- Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis
- (2008) Olivier Hermine et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started